XWELL (XWEL) Institutional Ownership → Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad) Free XWEL Stock Alerts $1.45 +0.05 (+3.57%) (As of 09:56 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for XWELL (NASDAQ:XWEL)CurrentInstitutional OwnershipPercentage8.67%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$23.00MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$11.39M Get XWEL Insider Trade Alerts Want to know when executives and insiders are buying or selling XWELL stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XWEL Institutional Buying and Selling by Quarter Ad DTIThis company has increased its dividend every year for 54 yearsThere are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). XWELL Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.183,501$319K0.0%-22.5%4.390% 2/15/2024Vanguard Group Inc.183,501$319K0.0%-22.5%4.390% 12/18/2023Vanguard Group Inc.236,914$533K0.0%-95.1%5.668% 8/11/2023BlackRock Inc.1,707,348$343K0.0%-7.6%2.045% 8/11/2023Geode Capital Management LLC983,465$197K0.0%-5.6%1.178% 5/16/2023Geode Capital Management LLC1,041,547$376K0.0%N/A1.249% 5/12/2023BlackRock Inc.1,847,881$667K0.0%N/A2.215% 5/9/2023Bank of New York Mellon Corp89,906$32K0.0%N/A0.108% 5/3/2023Integrated Wealth Concepts LLC207,000$75K0.0%N/A0.248% (Data available from 1/1/2016 forward) XWEL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XWEL shares? During the previous two years, the following institutional investors and hedge funds held shares of XWELL shares: BlackRock Inc. ($343K), Vanguard Group Inc. ($319K), Geode Capital Management LLC ($197K), and Integrated Wealth Concepts LLC ($75K), Bank of New York Mellon Corp ($32K).Learn more on XWEL's institutional investors. What percentage of XWELL stock is owned by institutional investors? 8.67% of XWELL stock is owned by institutional investors. Learn more on XWEL's institutional investor holdings. Which institutional investors have been buying XWELL stock? The following institutional investors have purchased XWELL stock in the last 24 months: BlackRock Inc. ($1.85M), Geode Capital Management LLC ($1.04M), Integrated Wealth Concepts LLC ($207K), and Bank of New York Mellon Corp ($89.91K). How much institutional buying is happening at XWELL? Institutional investors have bought a total of 3,186,334 shares in the last 24 months. This purchase volume represents approximately $23.00M in transactions. Which XWELL major shareholders have been selling company stock? The following institutional investors have sold XWELL stock in the last 24 months: Vanguard Group Inc. ($4.73M), BlackRock Inc. ($140.53K), and Geode Capital Management LLC ($58.08K). How much institutional selling is happening at XWELL? Institutional investors have sold a total of 4,931,050 shares in the last 24 months. This volume of shares sold represents approximately $11.39M in transactions. Related Companies: Avenue Therapeutics Major Shareholders Alzamend Neuro Major Shareholders Cadrenal Therapeutics Major Shareholders Silo Pharma Major Shareholders Seelos Therapeutics Major Shareholders Sonnet BioTherapeutics Major Shareholders Avinger Major Shareholders Enveric Biosciences Major Shareholders Genprex Major Shareholders Protagenic Therapeutics Major Shareholders This page (NASDAQ:XWEL) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XWELL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.